IP Library › Granted Patent US 11,413,436
Granted Patent B2
US 11,413,436 · App. 16/787,412 · Granted Aug 16, 2022

Disrupting fibrin sheath from a host blood vessel and visualization thereof

Inventors: Michael G. Tal (Woodbridge, CT); Ilan Carmel (Tel Mond, IL)
Assignee: A V Medical Technologies Ltd.
A61M25/104A61B17/1204A61B17/12109A61B17/12136A61B17/12168A61M5/007A61M5/14A61M25/0026A61M25/09A61M25/1011A61M29/02A61B6/481A61B6/504A61B2017/22001A61B2017/22082A61B2017/22084A61M2005/1403A61M2025/105A61M2025/1013A61M2025/1052A61M2025/1061A61M2025/1079
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,413,436
App. No.
16/787,412
Granted
Aug 16, 2022
Kind
B2
Abstract

A percutaneous transluminal angioplasty (PTA) catheter may be configured to perform vein expansion and occlusion. A infusion port located proximal to the occlusion feature can be used to inject contrast enhancement agent as well as other substances. The catheter can be used especially advantageously in vascular regions associated with hemodialysis access.

Claims (36)

1. A method for disrupting a fibrin sheath from a blood vessel and visualizing thereof, the method comprising:

introducing a dilation balloon catheter into the blood vessel, the dilation balloon catheter including a dilatation balloon and an infusion lumen having an infusion opening;

positioning the dilatation balloon adjacent to at least a portion of the fibrin sheath;

inflating the dilatation balloon to disrupt at least the portion of the fibrin sheath and occlude the blood vessel;

injecting a contrast enhancing material through the infusion opening and into blood vessel while the dilatation balloon is inflated and is occluding the blood vessel to enable visualization of at least the portion of the fibrin sheath; and

imaging the blood vessel to verify disruption of at least the portion of the fibrin sheath.

2. The method according to claim 1 , wherein the infusion opening opens laterally from the infusion lumen.

3. The method according to claim 1 , wherein the infusion opening is positioned proximal to the dilatation balloon.

4. The method according to claim 1 , wherein the blood vessel is a superior vena cava.

5. The method according to claim 1 , further comprising:

removing a first dialysis catheter from the blood vessel before introducing the dilation balloon catheter.

6. The method according to claim 5 , wherein removing the first dialysis catheter includes:

inserting a guide wire into the first dialysis catheter; and

removing the first dialysis catheter over the guide wire.

7. The method according to claim 5 , further comprising:

replacing the dilation balloon catheter with a second dialysis catheter.

8. The method according to claim 1 , wherein the infusion opening is located adjacent to the dilation balloon.

9. The method according to claim 1 , further comprising:

dispersing a thrombolytic agent through the infusion lumen.

10. The method according to claim 1 , further comprising:

deflating the dilatation balloon;

repositioning the dilation balloon adjacent a different portion of the fibrin sheath; and

repeating at least one of inflating the dilatation balloon, injecting the contrast enhancing material, and imaging of the blood vessel.

11. The method according to claim 1 , comprising:

flushing the contrast enhancing material to disperse beyond the fibrin sheath; and

visualizing a vasculature portion other than the blood vessel.

12. The method according to claim 11 , wherein the vasculature portion includes an internal jugular vein.

13. The method according to claim 11 , further comprising:

operating a valving mechanism disposed in the infusion lumen distally of the infusion opening, wherein injection of the contrast enhancing material follows operation of the valving mechanism such that injection of the contrast enhancing material causes the contrast enhancing material to primarily exit through the infusion opening.

14. The method according to claim 1 , wherein the infusion lumen includes a proximal opening and a distal opening that is distal of the dilatation balloon.

15. The method according to claim 14 , the method further includes:

inserting a guidewire into the blood vessel; and

inserting the dilation balloon catheter such that the guidewire extends into the infusion lumen from the distal opening to the proximal opening.

16. The method according to claim 15 , wherein the guidewire is configured to block a distal portion of the infusion lumen, such that injection of the contrast enhancing material causes the contrast enhancing material to primarily exit through the infusion opening.

17. The method according to claim 1 , wherein inflating the dilatation balloon includes elevating a pressure in the dilatation balloon to a maximal pressure up to 20 atmospheres.

18. The method according to claim 17 , wherein inflating the dilatation balloon further includes maintaining the maximal pressure for at least one minute.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2020
From: TAL, MICHAEL GABRIEL; CARMEL, ILAN
To: A V MEDICAL TECHNOLOGIES, LTD
Reel/Frame 051784/0366 →
Continuity (5)
Continuation 14413264
Provisional Application 61752649 · Jan 15, 2013
Provisional Application 61752743 · Jan 15, 2013
Provisional Application 61669284 · Jul 9, 2012
Related Publication 20200171283A1 · Jun 4, 2020